Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,169) with videos related to
Page
of 117
Sort By:
Science Translational Medicine
|
September 26, 2014
Clinical recovery from surgery correlates with single-cell immune signatures
Brice Gaudillière, Gabriela K Fragiadakis, Robert V Bruggner, et al.
Nature Biotechnology
|
February 5, 2025
SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci
Christopher R Chang, Vivasvan S Vykunta, Jae Hyun J Lee, et al.
Journal of Korean Medical Science
|
March 16, 2021
ARCO Consensus on the Pathogenesis of Non-traumatic Osteonecrosis of the Femoral Head
Quanjun Cui, Woo Lam Jo, Kyung Hoi Koo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 28, 2021
Late Conditions Diagnosed 1-4 Months Following an Initial Coronavirus Disease 2019 (COVID-19) Encounter: A Matched-Cohort Study Using Inpatient and Outpatient Administrative Data-United States, 1 March-30 June 2020
Jennifer R Chevinsky, Guoyu Tao, Amy M Lavery, et al.
The Journal of Clinical Investigation
|
August 2, 2011
Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis
Jason J Song, Inyong Hwang, Kyung H Cho, et al.
The Lancet. Oncology
|
September 22, 2012
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi, Howard I Scher, Arturo Molina, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 22, 2023
Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming
Chima V Maduka, Mohammed Alhaj, Evran Ural, et al.
The Lancet. Oncology
|
October 3, 2021
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study
Fred Saad, Eleni Efstathiou, Gerhardt Attard, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4)
Carl A Brooks, Linda S Barton, David J Behm, et al.
JAMA Network Open
|
June 7, 2021
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children
Lyudmyla Kompaniyets, Nickolas T Agathis, Jennifer M Nelson, et al.
Page
of 117
Search research articles
Search
Showing results (1101-1110 of 1,169) with videos related to
Sort By:
Page
of 117
Science Translational Medicine
|
September 26, 2014
Clinical recovery from surgery correlates with single-cell immune signatures
Brice Gaudillière, Gabriela K Fragiadakis, Robert V Bruggner, et al.
Nature Biotechnology
|
February 5, 2025
SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci
Christopher R Chang, Vivasvan S Vykunta, Jae Hyun J Lee, et al.
Journal of Korean Medical Science
|
March 16, 2021
ARCO Consensus on the Pathogenesis of Non-traumatic Osteonecrosis of the Femoral Head
Quanjun Cui, Woo Lam Jo, Kyung Hoi Koo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 28, 2021
Late Conditions Diagnosed 1-4 Months Following an Initial Coronavirus Disease 2019 (COVID-19) Encounter: A Matched-Cohort Study Using Inpatient and Outpatient Administrative Data-United States, 1 March-30 June 2020
Jennifer R Chevinsky, Guoyu Tao, Amy M Lavery, et al.
The Journal of Clinical Investigation
|
August 2, 2011
Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis
Jason J Song, Inyong Hwang, Kyung H Cho, et al.
The Lancet. Oncology
|
September 22, 2012
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi, Howard I Scher, Arturo Molina, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 22, 2023
Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming
Chima V Maduka, Mohammed Alhaj, Evran Ural, et al.
The Lancet. Oncology
|
October 3, 2021
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study
Fred Saad, Eleni Efstathiou, Gerhardt Attard, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4)
Carl A Brooks, Linda S Barton, David J Behm, et al.
JAMA Network Open
|
June 7, 2021
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children
Lyudmyla Kompaniyets, Nickolas T Agathis, Jennifer M Nelson, et al.
Page
of 117